Back to top
more

Thermo Fisher Scientific (TMO)

(Real Time Quote from BATS)

$601.84 USD

601.84
450,979

+4.92 (0.82%)

Updated Oct 14, 2024 03:20 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 38% (96 out of 250)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Bruker (BRKR) Launches PCR Panel, Expands Testing Portfolio

by Zacks Equity Research

Bruker's (BRKR) winter four-plex panel is expected to facilitate diagnosis and patient management by facilitating the use of saliva samples as well.

Here's Why You Should Hold on to QIAGEN (QGEN) Stock for Now

by Zacks Equity Research

Investors continue to be optimistic about QIAGEN (QGEN) on robust segmental and geographical growth.

    IDEXX (IDXX) Gains on CAG Sales, Global Growth Remains Robust

    by Zacks Equity Research

    IDEXX (IDXX) sees sturdy gains in CAG Diagnostics recurring revenues, supported by high organic gains in both U.S. and International markets.

    Syneos Health (SYNH) Buys Illingworth Research, Expands CRO Base

    by Zacks Equity Research

    Syneos Health (SYNH) is currently working on bringing greater flexibility to each customer study, based on data, people, process and technology.

      Globus Medical (GMED) Gains From Robot Sales Amid Pandemic Blues

      by Zacks Equity Research

      Globus Medical (GMED) saw a visible rebound in its revenue trend in the third quarter.

      Abbott (ABT) Broadens Pediatric Client Base With New Labeling

      by Zacks Equity Research

      Abbott's (ABT) HeartMate 3 LVAD or heart pump is an implantable device that pumps blood through the body in people whose hearts are too weak to do so naturally.

      Thermo Fisher Scientific (TMO) Outpaces Stock Market Gains: What You Should Know

      by Zacks Equity Research

      In the latest trading session, Thermo Fisher Scientific (TMO) closed at $464.51, marking a +1.47% move from the previous day.

      Varian (VAR) Inks Deal With Yonsei Cancer Center in Korea

      by Zacks Equity Research

      Varian (VAR) will be coordinating with Yonsei Cancer Center on formulating AI solutions, which are proven to upgrade early detection of cancer.

      Debanjana Dey headshot

      5 MedTech Stocks That Have Outperformed the Industry in 2020

      by Debanjana Dey

      Here are a few MedTech stocks which continued to outperform their respective industries amid the pandemic and can turn out to be wise investment choices.

      Cerner (CERN) to Buy Kantar Health to Enhance Clinical Research

      by Zacks Equity Research

      Cerner (CERN) agrees to acquire Kantar Health to drive safety and efficiency of clinical research across life sciences, pharmaceuticals and health care.

      Medtronic (MDT) Releases Positive Study Results of RFA Therapy

      by Zacks Equity Research

      Medtronic's (MDT) OsteoCool RFA System is expected to provide better relief from debilitating pain for cancer patients.

      Here's Why You Should Add Hologic (HOLX) to Your Portfolio

      by Zacks Equity Research

      Investors continue to be optimistic about Hologic (HOLX) on robust growth of the Diagnostics segment and regulatory approvals.

      Here's Why You Should Hold onto Varian Medical (VAR) Stock Now

      by Zacks Equity Research

      Investor confidence is high on Varian Medical (VAR) stock, courtesy of solid prospects.

      Zimmer Biomet (ZBH) Shows Strong Recovery Amid COVID-19 Woes

      by Zacks Equity Research

      Owing to lack of clarity around the scope and duration of the coronavirus pandemic, Zimmer Biomet (ZBH) is unable to gauge the impact on its overall business in 2020.

      Abbott (ABT) Gains CE Mark for Quantitative Serology Testing

      by Zacks Equity Research

      The test is set to be used on Abbott's (ABT) ARCHITECT and Alinity i platforms.

      Veeva (VEEV) Vault QMS Gets Picked by Samsung Biologics

      by Zacks Equity Research

      Veeva Systems' (VEEV) Vault Quality Suite gets selected by Samsung Biologics to drive quality process and content management for better visibility across the latter's global processes.

        Here's Why You Should Retain AMN Healthcare (AMN) Stock Now

        by Zacks Equity Research

        AMN Healthcare (AMN) continues to gain traction from its wide range of services, and Healthcare MSP. Intense competition remains a woe.

          NextGen's (NXGN) HDH to Facilitate Health Information Exchange

          by Zacks Equity Research

          NextGen's (NXGN) HDH has been chosen by HI-BRIDGE HIE for secure sharing of patient health data from multiple sources.

            Abbott (ABT) Launches Immunity Boosting Hydration Solution

            by Zacks Equity Research

            Abbott's (ABT) latest hydration solution with specifically chosen nutrients along with optimal balance of electrolytes and glucose is expected to boost immunity.

            Masimo (MASI) Releases Favorable Findings on Pulse Oximetry

            by Zacks Equity Research

            Researchers on probe discover that the use of Masimo's (MASI) SpHb was related to the lower rate of postoperative transfusion, minimal duration of ICU stay and other better outcomes.

            NEOGEN (NEOG) Launches DNA Screening Tool for Canine Care

            by Zacks Equity Research

            NEOGEN's (NEOG) latest DNA screening tool is expected to aid veterinarians to provide healthy lifestyle recommendations for a longer and happier life for each pet and its family.

            Here's Why You Should Retain Fresenius Medical (FMS) Stock

            by Zacks Equity Research

            Fresenius Medical (FMS) continues to gain traction from its broad range of dialysis products and services. However, intense competition remains a woe.

            Cerner's (CERN) Simplified Digital Tools to Aid Health Systems

            by Zacks Equity Research

            Cerner (CERN) offers centralized digital ordering and monitoring for clients in order to help health systems.

            Thermo Fisher Scientific (TMO) Gains As Market Dips: What You Should Know

            by Zacks Equity Research

            Thermo Fisher Scientific (TMO) closed the most recent trading day at $471.39, moving +0.57% from the previous trading session.

            Zimmer Biomet (ZBH), HSS Partner to Advance Remote Patient Care

            by Zacks Equity Research

            Zimmer Biomet's (ZBH) mymobility with Apple Watch platform aids in transforming virtual patient care via the latest partnership with HSS.